Flunixin meglumin
CAS No. 42461-84-7
Flunixin meglumin( NIH 10250 )
Catalog No. M14442 CAS No. 42461-84-7
Flunixin Meglumin is a potent inhibitor of the enzyme cyclooxygenase used as analgesic agent with anti-inflammatory and antipyretic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
500MG | 38 | In Stock |
|
1G | 59 | In Stock |
|
Biological Information
-
Product NameFlunixin meglumin
-
NoteResearch use only, not for human use.
-
Brief DescriptionFlunixin Meglumin is a potent inhibitor of the enzyme cyclooxygenase used as analgesic agent with anti-inflammatory and antipyretic activity.
-
DescriptionFlunixin Meglumin is a potent inhibitor of the enzyme cyclooxygenase used as analgesic agent with anti-inflammatory and antipyretic activity.(In Vitro):flunixin meglumine (10-1000 μM, 2 h) inhibits lipopolysaccharide (LPS)-induced activity of inducible nitric oxide synthase (iNOS) in RAW 264.7 murine macrophages.flunixin meglumine (10-1000 μM, 2 h) inhibits lipopolysaccharide-induced activation of nuclear factor kappa B (NfκB) in RAW 264.7 murine macrophages.(In Vivo):Flunixin meglumine (intravenous injection; 1.1 mg/kg; once) treatment inhibits the formation of exudate PGE2 and serum TXB2.
-
In Vitroflunixin meglumine (10-1000 μM, 2 h) inhibits lipopolysaccharide (LPS)-induced activity of inducible nitric oxide synthase (iNOS) in RAW 264.7 murine macrophages.flunixin meglumine (10-1000 μM, 2 h) inhibits lipopolysaccharide-induced activation of nuclear factor kappa B (NfκB) in RAW 264.7 murine macrophages. Cell Viability Assay Cell Line:RAW 264.7 murine macrophages Concentration:10, 100, 300, and 1000 μM Incubation Time:2 hours Result:Inhibited LPS-induced nitric oxide release at concentrations between 100 and 1,000 μM (P=0.01).
-
In VivoFlunixin meglumine (intravenous injection; 1.1 mg/kg; once) treatment inhibits the formation of exudate PGE2 and serum TXB2. Animal Model:Male sheep injected with Carrageenan Dosage:1.1 mg/kg Administration:Intravenous injection; 1.1 mg/kg; once Result:Inhibited Carrageenan-induced exudate PGE2 formation (Emax, 100%, IC50, <0.4 nM) and serum TXB2 generation (Emax, 100%, IC50, 17 nM) for up to 32 h.
-
SynonymsNIH 10250
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-1| COX-2
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number42461-84-7
-
Formula Weight491.46
-
Molecular FormulaC21H28F3N3O7
-
Purity>98% (HPLC)
-
SolubilityEthanol: 8 mg/mL (16.27 mM); Water: 98 mg/mL (199.4 mM); DMSO: 98 mg/mL (199.4 mM)
-
SMILESO=C(C1=CC=CN=C1NC2=CC=CC(C(F)(F)F)=C2C)O.O[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)CNC
-
Chemical Name(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)nicotinate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Duz M, et al. Am J Vet Res. 2015 Mar;76(3):208-15.
molnova catalog
related products
-
Roflumilast N-oxide
Roflumilast N-oxide is a PDE type 4 inhibitor.
-
Phenetidine
Used in the manufacture of acetophenetidin.
-
TFAP
TFAP is a selective cyclooxygenase-1 (COX-1) inhibitor.